Company Filing History:
Years Active: 2009-2013
Title: Cheng-Kung Hu: Innovator in Heterocyclic and Pyrimidine Compounds
Introduction
Cheng-Kung Hu is a notable inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of medicinal chemistry, particularly through his work on heterocyclic and pyrimidine compounds. With a total of 3 patents, his innovations aim to address various inflammatory and immune diseases.
Latest Patents
One of his latest patents involves heterocyclic compounds, which are designed to treat inflammatory diseases, immune diseases, developmental or degenerative diseases, and tissue injuries. This invention relates to specific formulas outlined in the patent specification. Another significant patent focuses on pyrimidine compounds, detailing a method for treating similar health issues by administering effective amounts of these compounds to subjects in need.
Career Highlights
Cheng-Kung Hu has worked with Taigen Biotechnology Company, Ltd. and Taigen Biotechnology, where he has applied his expertise in developing innovative solutions for health-related challenges. His work has contributed to advancements in therapeutic methods that can potentially improve patient outcomes.
Collaborations
Cheng-Kung Hu has collaborated with notable colleagues such as Chi-Feng Yen and Ying-Huey Huang, enhancing the research and development efforts in his field.
Conclusion
Cheng-Kung Hu's contributions to the field of medicinal chemistry through his patents on heterocyclic and pyrimidine compounds highlight his role as an innovator. His work continues to pave the way for new treatments for various diseases, showcasing the importance of innovation in healthcare.